Sarcoidosis
BMJ 339:620-625, Dempsey,O.,et al, 2009
Practice Parameter: Evaluation of the Child with Microcephaly (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 73:887-897, Ashwal,S.,et al, 2009
Strokes After Cardiac Surgery and Relationship to Carotid Stenosis
Arch Neurol 66:1091-1096, 1062, Li,Y.,et al, 2009
Cranial Dural Arteriovenous Fistula: Diagnosis and Classification with Time-Resolved MR Angiography at 3T
AJNR 30:1546-1551, Farb,R.I.,et al, 2009
CT Angiography for Brain Death Diagnosis
AJNR 30:1566-1570, Frampas,E.,et al, 2009
Brainstem Lesions in Diffusion Sequences of MRI Can be Reversible After Arterial Recanalization
Neurol 73:813-815, Vilas,D., 2009
Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009
Outcome of Symptomatic Intracranial Atherosclerotic Disease
Stroke 40:2983-2987, Samaniego,E.,et al, 2009
Akinetopsia in the Posterior Cortical Variant of Alzheimer Disease
Neurol 73:731-732, Tsai,P. &Mendez,M.F., 2009
Systematic Characterization of the Computed Tomography Angiography Spot Sign in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk for Hematoma Expansion: The Spot Sign Score
Stroke 40:2994-3000, Delgado,J.,et al, 2009
Long-Term Outcome After Surgical Treatment for Space-Occupying Cerebellar Infarction: Experience in 56 Patients
Stroke 40:3060-3066, J�ttler,E.,et al, 2009
Long-Term Outcome After Suboccipital Decompressive Craniectomy for Malignant Cerebellar Infarction
Stroke 40:3045-3050, Pfefferkorn,T.,et al, 2009
Effect of Hyperthermia on Prognosis After Acute Ischemic Stroke
Stroke 40:3051-3059, Saini,M.,et al, 2009
Collateral Vessels on CT Angiography Predict Outcome in Acute Ischemic Stroke
Stroke 40:3001-3005, Maas,M.B.,et al, 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009
National Institutes of Health Stroke Scale Score Is Poorly Predictive of Proximal Occlusion in Acute Cerebral Ischemia
Stroke 40:2988-2993, Maas,M.B.,et al, 2009
DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009
Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009
Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke 40:2893-2898, Morris,J.G.,et al, 2009
Anosmia After Perimesencephalic Nonaneurysmal Hemorrhage
Stroke 40:2885-2886, Greebe,P.,et al, 2009
Strokes at Time of Disease Diagnosis in a Series of 287 Patients with Biopsy-Proven Giant Cell Arteritis
Medicine 88:227-235, Gonzalez-Gay,M.A.,et al, 2009
Urgency of Carotid Endarterectomy for Secondary Stroke Prevention: Results from the Registry of the Canadian Stroke Network
Stroke 40:2776-2782, Gladstone,D.J.,et al, 2009
Validation and Refinement of the ABCD2 Score: A Population-Based Analysis
Stroke 40:2669-2673, Fothergill,A.,et al, 2009
Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009
MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009
Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009
A 75-Year-Old Woman with Progressive Right-Hand Tremor and Inability to Use Her Right Side
Neurol 73:1399-1405, Kertesz,A.,et al, 2009
Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
Stroke 40:3646-3678, Latchaw,R.,et al, 2009
Diagnostic Usefulness of the ABCD Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events: The North Dublin TIA Study
Stroke 40:3449-3454, Sheehan,O.,et al, 2009
Increased Risk of Stroke After a Herpes Zoster Attack
Stroke 40:3443-3448, Kang,J.,et al, 2009
Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
Stroke 40:e622-e623, Manktelow,B. &Potter,J., 2009
Surgery for Primary Supratentorial Intracerebral Hematoma: A Meta-Analysis of 10 Randomized Controlled Trials
Stroke 40:e624-e626, Prasad,K.,et al, 2009
Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009
HINTS to Diagnose Stroke in the Acute Vestibular Syndrome: Three-Step Bedside Oculomotor Examination More Sensitive Than Early MRI Diffusion-Weighted Imaging
Stroke 40:3504-3510, Kattah,J.,et al, 2009
Cerebral Microbleeds Are Frequent in Infective Endocarditis; A Case-Control Study
Stroke 40:3461-3465, Klein,I.,et al, 2009
Periodontitis and Incidence of Cerebrovascular Disease in Men
Ann Neurol 66:505-512, Jimenez,M.,et al, 2009
Superficial Siderosis in the General Population
Neurol 73:202-205, Vernooij,M.W.,et al, 2009
CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009
Clinicopath Conf., Atypical Hemolytic-Uremic Syndrome
NEJM 361:389-400, Case 23-2009, 2009
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Stroke 40:2349-2355, Alsheikh-Ali,A.A.,et al, 2009
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009
Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Influence of Weekend Hospital Admission on Short-Term Mortality After Intracerebral Hemorrhage
Stroke 40:2387-2392, Crowley,R.W.,et al, 2009
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009
Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009
Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009
A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement from the American Heart Association/American Stroke Association
Stroke 40:2616-2634, Schwamm,L.H.,et al, 2009